RE: Remission18 Apr 2018 11:06
I agree with you....without the numbers, % means nothing.......
I also find it strange that in the RNS ..... (p value not currently available).
"Lupuzor� also demonstrated a superior response rate over placebo (68.8% vs 59.2%) in the 153 patients who completed the study (p value not currently available). "
while we had the p value for the following...
Importantly, in patients who had anti-dsDNA autoantibodies (a recognised biomarker for Systemic Lupus Erythematosus ('SLE')), Lupuzor� demonstrated a superior response rate over placebo (61.5% vs 47.3%, p = 0.0967).
Anyone able to explain this ?